People who read know that I am most of the time in a European time zone.
Those who can’t… well, LOL
Europe has been part of the lovely’ Cytodyn story. The EMA (FDA equivalent) has reviewed Leronlimab‘s bad statistical results, and said « no thank you ». Exactly like the FDA.
Market Data 
Markets 
AI
